[Evolution of the need and coverage of opioid substitution treatments and needle exchange programmes in Spanish prisons, 1992-2009].

INTRODUCTION Spain is one of the few countries to have widely implemented opioid substitution treatments (OST) and needle exchange programmes (NEP) for drug users in prison. We analyze the evolution of the need, coverage and the timeliness of these interventions in Spain between 1992 and 2009. METHODS Data on the provision of interventions is taken from official publications. The need was calculated by applying multiplicative methods to secondary data from several sources. Coverage was estimated as the quotient between provision and need. Temporal opportunity was estimated by observing the gap between the acme of the incidence of consumption, of HIV infection or need and the curve of provision. RESULTS OST's began to be implemented in 1992. In 2002 they reached their maximum coverage (63.8%) and subsequently stabilized. NEP's started in 1997. Their maximum coverage reached 20.7% in 2006, but halved in a period of two years. The delay between the epidemic acme and the need and maximum intervention coverage was of 8-25 years. CONCLUSIONS OST and NEP introduction in Spanish prisons was a great advance, but the delay in their implementation and the low level of NEP coverage could have limited their potential impact on the improvement of the health of incarcerated drug users. The decline of NEP coverage in recent years is a cause of major concern for the evolution of HIV and Hepatitis C epidemics.

[1]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .

[2]  M. Villanueva Programa de Intercambio de Jeringuillas en el Centro Penitenciario de Pamplona , 2012 .

[3]  Lf Barrios Flores Origen y modelos de Programa de Intercambio de Jeringuillas (PIJ) en prisión , 2012 .

[4]  E. Regidor,et al.  Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates. , 2012, Addiction.

[5]  J. Arroyo-Cobo Public health gains from health in prisons in Spain. , 2010, Public health.

[6]  T. Rhodes,et al.  Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed , 2010, The Lancet.

[7]  J. Montaner,et al.  Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. , 2010, American journal of public health.

[8]  S. Larney Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review. , 2010, Addiction.

[9]  J. Arroyo-Cobo,et al.  Resultados de la experiencia española: una aproximación global al VIH y al VHC en prisiones , 2010 .

[10]  J. Fortiana,et al.  Problematic heroin use incidence trends in Spain. , 2009, Addiction.

[11]  G. Barrio,et al.  More free syringes, fewer drug injectors in the case of Spain. , 2007, Social science & medicine.

[12]  R. Coutinho,et al.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users , 2007, Addiction.

[13]  R. Bluthenthal,et al.  Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. , 2007, Drug and alcohol dependence.

[14]  A. Domingo-Salvany,et al.  MÁS DE TREINTA AÑOS DE DROGAS ILEGALES EN ESPAÑA: UNA AMARGA HISTORIA CON ALGUNOS CONSEJOS PARA EL FUTURO , 2006 .

[15]  A. Gatherer,et al.  The World Health Organization European Health in Prisons Project after 10 years: persistent barriers and achievements. , 2005, American journal of public health.

[16]  G. Barrio,et al.  Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  D. Vlahov,et al.  Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. , 2001, American journal of epidemiology.

[18]  J. Castilla,et al.  Evolución del número de personas infectadas por el virus de la inmunodeficiencia humana y de los casos de sida en España: 1980–1998 , 2000 .

[19]  G. Barrio,et al.  Intravenous administration among heroin users having treatment in Spain. , 1994, International journal of epidemiology.

[20]  T. S. Jones,et al.  Inadequate bleach contact times during syringe cleaning among injection drug users. , 1994, Journal of acquired immune deficiency syndromes.

[21]  D. Mash,et al.  Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. , 1994, Journal of acquired immune deficiency syndromes.

[22]  T. Hernández-Fernández,et al.  [Results of the Spanish experience: a comprehensive approach to HIV and HCV in prisons]. , 2010, Revista Española de Sanidad Penitenciaria.

[23]  T. Rhodes,et al.  Harm Reduction: Evidence, Impacts and Challenges , 2010 .

[24]  A. Verster,et al.  Interventions to reduce HIV transmission related to injecting drug use in prison. , 2009, The Lancet. Infectious diseases.

[25]  Crime.,et al.  WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users.. , 2009 .

[26]  D. Zulaica,et al.  Needle exchange programs in prisons in Spain. , 2000, Canadian HIV/AIDS policy & law review.